Skip to content

Clinical trials

Schizophrenia trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Hungary Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20045
20052
20061
20074
20084
20106
20113
20122
20132
20141
20151
20163
20174
20182
20191
20201
20212
20224
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated9
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.9
AstraZeneca6
Janssen-Cilag International NV5
ACADIA Pharmaceuticals Inc.4
Hoffmann-La Roche3
AbbVie2
Boehringer Ingelheim2
H. Lundbeck A/S2
Janssen Research & Development, LLC2
Solvay Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia53
Psychotic Disorders4
Mental Disorders3
Autistic Disorder2
Cognitive Dysfunction2
Schizophrenia Spectrum and Other Psychotic Disorders2
Bipolar Disorder1
Body Weight Changes1
Mania1
Metabolic Syndrome1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.